Publication | Closed Access

Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients

HlaHistocompatibilityTransplant RejectionKidney Transplantation RecipientsTransplantationAutoimmune DiseaseKidney TransplantHuman Leukocyte AntigenImmunologyHematologyPathologyRisk FactorAntibody-mediated RejectionAutoimmunityHla TypingImmunotherapyMedicineGraft Rejection